Literature DB >> 22923370

Synthesis and characterization of novel n-9 fatty acid conjugates possessing antineoplastic properties.

Azmat A Khan1, Ahmad Husain, Mumtaz Jabeen, Jamal Mustafa, Mohammad Owais.   

Abstract

The present study enumerates the synthesis, spectroscopic characterization, and evaluation of anticancer potential of esters of two n-9 fatty acids viz., oleic acid (OLA) and ricinoleic acid (RCA) with 2,4- or 2,6-diisopropylphenol. The synthesis strategy involved esterification of the hydroxyl group of diisopropylphenol (propofol) to the terminal carboxyl group of n-9 fatty acid. The synthesized propofol-n-9 conjugates having greater lipophilic character were tested initially for cytotoxicity in-vitro. The conjugates showed specific growth inhibition of cancer cell lines whereas no effect was observed in normal cells. In general, pronounced growth inhibition was found against the human skin malignant melanoma cell line (SK-MEL-1). The anticancer potential was also determined by testing the effect of these conjugates on cell migration, cell adhesion and induction of apoptosis in SK-MEL-1 cancer cells. Propofol-OLA conjugates significantly induced apoptosis in contrast to propofol-RCA conjugates which showed only weak signals for cytochrome c. Conclusively, the synthesized novel ester conjugates showed considerable moderation of anti-tumor activity. This preliminary study places in-house synthesized conjugates into the new class of anticancer agents that possess selectivity toward cancer cells over normal cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923370     DOI: 10.1007/s11745-012-3707-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  43 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets.

Authors:  J F Coetzee; J B Glen; C A Wium; L Boshoff
Journal:  Anesthesiology       Date:  1995-06       Impact factor: 7.892

3.  Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA).

Authors:  M Takahashi; M Fukutake; T Isoi; K Fukuda; H Sato; K Yazawa; T Sugimura; K Wakabayashi
Journal:  Carcinogenesis       Date:  1997-07       Impact factor: 4.944

4.  Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells.

Authors:  J A Menendez; S Ropero; R Lupu; R Colomer
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

5.  Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.

Authors:  J A Menendez; L Vellon; R Colomer; R Lupu
Journal:  Ann Oncol       Date:  2005-01-10       Impact factor: 32.976

6.  Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis.

Authors:  A K Masood; S M Faisal; W Haque; M Owais
Journal:  J Drug Target       Date:  2002-05       Impact factor: 5.121

7.  Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells.

Authors:  Francesco Natali; Luisa Siculella; Serafina Salvati; Gabriele V Gnoni
Journal:  J Lipid Res       Date:  2007-06-13       Impact factor: 5.922

8.  Induction and mechanism of apoptotic cell death by propofol in HL-60 cells.

Authors:  M Tsuchiya; A Asada; K Arita; T Utsumi; T Yoshida; E F Sato; K Utsumi; M Inoue
Journal:  Acta Anaesthesiol Scand       Date:  2002-10       Impact factor: 2.105

9.  Comparative molecular field analysis and synthetic validation of a hydroxyamide-propofol binding and functional block of neuronal voltage-dependent sodium channels.

Authors:  Milton L Brown; Hilary A Eidam; Mikell Paige; Paulianda J Jones; Manoj K Patel
Journal:  Bioorg Med Chem       Date:  2008-12-03       Impact factor: 3.641

10.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.

Authors:  Rafat A Siddiqui; Mustapha Zerouga; Min Wu; Alicia Castillo; Kevin Harvey; Gary P Zaloga; William Stillwell
Journal:  Breast Cancer Res       Date:  2005-06-07       Impact factor: 6.466

View more
  6 in total

1.  Biophysical Interactions of Novel Oleic Acid Conjugate and its Anticancer Potential in HeLa Cells.

Authors:  Azmat Ali Khan; Amer M Alanazi; Mumtaz Jabeen; Mohammad Khalid Parvez; Khalid Pervez; Rizwan Wahab; Ali Saber Abdelhameed; Arun Chauhan
Journal:  J Fluoresc       Date:  2015-02-01       Impact factor: 2.217

2.  Determination of anticancer potential of a novel pharmacologically active thiosemicarbazone derivative against colorectal cancer cell lines.

Authors:  Azmat Ali Khan; Rehan Ahmad; Amer M Alanazi; Nawaf Alsaif; Maha Abdullah; Tanveer A Wani; Mashooq A Bhat
Journal:  Saudi Pharm J       Date:  2022-03-31       Impact factor: 4.562

3.  Evaluation of Transition Metal Complexes of Benzimidazole-Derived Scaffold as Promising Anticancer Chemotherapeutics.

Authors:  Afzal Hussain; Mohamed F AlAjmi; Md Tabish Rehman; Azmat Ali Khan; Perwez Alam Shaikh; Rais Ahmad Khan
Journal:  Molecules       Date:  2018-05-21       Impact factor: 4.411

4.  Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment.

Authors:  Mohsin Kazi; Mohammed Al-Swairi; Ajaz Ahmad; Mohammad Raish; Fars K Alanazi; Mohamed M Badran; Azmat Ali Khan; Amer M Alanazi; Muhammad Delwar Hussain
Journal:  Front Pharmacol       Date:  2019-05-02       Impact factor: 5.810

5.  Transdifferentiation of MALME-3M and MCF-7 Cells toward Adipocyte-like Cells is Dependent on Clathrin-mediated Endocytosis.

Authors:  Jaime Carcel-Trullols; Cristóbal Aguilar-Gallardo; Fernando Garcia-Alcalde; Miguel Angel Pardo-Cea; Joaquin Dopazo; Ana Conesa; Carlos Simón
Journal:  Springerplus       Date:  2012-10-30

6.  Design, Synthesis, and Biological Evaluation of Benzimidazole-Derived Biocompatible Copper(II) and Zinc(II) Complexes as Anticancer Chemotherapeutics.

Authors:  Mohamed F AlAjmi; Afzal Hussain; Md Tabish Rehman; Azmat Ali Khan; Perwez Alam Shaikh; Rais Ahmad Khan
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.